RAD
Click for more information
8.11% 3.4¢ radiopharm theranostics limited

Ann: FDA Pre-IND meeting supports an IND application for RAD 101, page-4

  1. ttseng13
    68 Posts.
    lightbulb Created with Sketch. 8
    clock Created with Sketch.
    29/05/23
    11:48
    Post #: 68012515
    It is the short-cut for sure.
    FDA dont usually suggest a Ph2b/3 right after Ph1b/2a, given the sample size of RAD101 trial history.
    Sometimes they still require a complete Ph2 to test on patient in different doses.
    Last edited by ttseng13: 29/05/23
    RAD Price at posting: 14.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAD (ASX) to my watchlist
(20min delay)
Last
3.4¢ 		Change
-0.003(8.11%) 		Mkt cap ! $37.01M
Open High Low Value Volume
3.5¢ 3.6¢ 3.4¢ $75.34K 2.148M

Buyers (Bids)

No. Vol. Price($)
1 84368 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 261529 6
View Market Depth
Last trade - 11.02am 20/08/2024 (20 minute delay) ?
RAD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.